Cargando…
Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A
Translation is regulated predominantly at the initiation phase by several signal transduction pathways that are often usurped in human cancers, including the PI3K/Akt/mTOR axis. mTOR exerts unique administration over translation by regulating assembly of eukaryotic initiation factor (eIF) 4F, a hete...
Autores principales: | Cencic, R, Robert, F, Galicia-Vázquez, G, Malina, A, Ravindar, K, Somaiah, R, Pierre, P, Tanaka, J, Deslongchamps, P, Pelletier, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730203/ https://www.ncbi.nlm.nih.gov/pubmed/23872707 http://dx.doi.org/10.1038/bcj.2013.25 |
Ejemplares similares
-
Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia
por: Nasr, Zeina, et al.
Publicado: (2013) -
Targeting Translation Dependence in Cancer
por: Malina, Abba, et al.
Publicado: (2011) -
CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A
por: Chu, Jennifer, et al.
Publicado: (2016) -
Regulation of Eukaryotic Initiation Factor 4AII by MyoD during Murine Myogenic Cell Differentiation
por: Galicia-Vázquez, Gabriela, et al.
Publicado: (2014) -
Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma
por: Skofler, Christina, et al.
Publicado: (2021)